New Low-Light Level Therapy Shows Promising Results for CCCA REVIAN Inc. revealed positive outcomes for the use of REVIAN Red System to treat patients with Central Centrifugal Cicatricial Alopecia (CCCA).1 Researchers at Wake Forest University School of Medicine in Salem-West,
REVIAN® RED System, Among the Best Hair-Loss Treatments According to Doctors New York Magazine names REVIAN RED as Best Light Treatment Cap for Hair Loss Durham, N.C., December 16, 2021 – REVIAN Inc., an aesthetic medical technology company dedicated to stimulating
You’re Not Imagining It: The Pandemic Is Triggering Stress-Induced Hair Loss In a recent article published by Allure Magazine, several prominent dermatologists share their thoughts surrounding the increasing rates of hair loss as a result of the COVID-19 pandemic. Joshua Zeichner,
REVIAN Wins 2020 MedTech Breakthrough Award for Hair Loss Technology Innovation DURHAM, N.C. – May 19, 2020 – REVIAN Inc., a medical technology company dedicated to stimulating the body’s natural processes to rejuvenate hair and skin with light, today announced that
REVIAN® Presents Leading Clinical Trial Results for New Hair Loss Treatment DURHAM, N.C., Jan. 21, 2020/Business Wire/ — REVIAN Inc. (formerly PhotonMD Inc.) – a medical technology company dedicated to stimulating the body’s natural processes to rejuvenate hair and skin with light
REVIAN® Inc. Announces Issuance of Landmark Patent Covering the Use of Light to Stimulate the Body to Heal Itself DURHAM, N.C., Jan. 10, 2020/Business Wire/ — REVIAN Inc. (formerly PhotonMD Inc.), a medical technology company dedicated to stimulating the body’s natural processes to rejuvenate hair and skin with light, is
PhotonMD® Announces Commercial Sales of REVIAN® RED System DURHAM, N.C., Apr. 2, 2019 — PhotonMD, Inc., an innovative photomedicine device company, announced its REVIAN RED system, an FDA cleared, over-the-counter (OTC) light therapy system for the treatment of androgenetic alopecia
REVIAN® RED Light Therapy Safe and Effective for Hair Growth DURHAM, N.C. – PhotonMD, Inc., a technology company specializing in the advancement of precise light based medical treatments, today announced positive topline results from a pivotal clinical trial assessing a series